Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nathalie Grace Sy Chua"'
Autor:
Kelvin Kau-Kiat Goh, Wilson Ghim-Hon Toh, Daryl Kim-Hor Hee, Edwin Zhi-Wei Ting, Nathalie Grace Sy Chua, Farah Iffah Binte Zulkifli, Li-Jiao Sin, Thuan-Tong Tan, Andrea Lay-Hoon Kwa, Tze-Peng Lim
Publikováno v:
Antibiotics, Vol 11, Iss 1, p 54 (2022)
Fosfomycin-based combination therapy has emerged as an attractive option in our armamentarium due to its synergistic activity against carbapenem-resistant Gram-negative bacteria (CRGNB). The ability to simultaneously measure fosfomycin and other anti
Externí odkaz:
https://doaj.org/article/fa4a40f5a2924a7d92343a43addd8f3f
Autor:
Yvonne Peijun Zhou, Nathalie Grace Sy Chua, Maciej Piotr Chlebicki, Winnie Hui Ling Lee, Andrea Lay Hoon Kwa
Publikováno v:
Case Reports in Infectious Diseases, Vol 2014 (2014)
Recent pharmacokinetic studies have suggested that nonrenal clearance predominates the elimination of polymyxin B. We present 2 patients with preexisting end stage renal failure, who were given nonattenuated doses of polymyxin B for the treatment of
Externí odkaz:
https://doaj.org/article/bea4efea37044977b2865604d3948b55
Autor:
Shena Yun Chun Lim, Peijun Yvonne Zhou, Daphne Yah Chieh Yii, Kai Chee Hung, Lai Wei Lee, Yi Xin Liew, Jia Le Lim, Li Wen Loo, Narendran Koomanan, Nathalie Grace Sy Chua, Benjamin Pei Zhi Cherng, Siew Yee Thien, Winnie Lee, Lay Hoon Andrea Kwa, Shimin Jasmine Chung
Publikováno v:
Open Forum Infectious Diseases
Background In early months of COVID-19 pandemic, SGH recorded a year-on-year increase in antibiotic (ABx) use for community acquired acute respiratory infection (CA ARI) from Feb-Apr 2019 (48.7 defined daily doses (DDD)/100 bed-days) to 2020 (50.8 DD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f88c11deb050544222adae25521b9cdb
http://europepmc.org/articles/PMC8690381
http://europepmc.org/articles/PMC8690381